Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Response of Supraclavicular Block Volume on Hemidiaphragmatic Paresis
NCT03138577Phase 4Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Feb 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mepivacaine, bupivacaine hydrochloride 0.75% injection in surgical anesthesia, sponsored by Weill Cornell Medicine. Started Feb 2018; status: completed.
02
Drugs
mepivacainebupivacaine hydrochloride 0.75% injection
03
Conditions
surgical anesthesia
Beyond the preview
Go deeper on NCT03138577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03138577.